docosyl-triethylenetetraminepentaacetic acid has been researched along with Osteoporosis, Postmenopausal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kenner, GH; Liu, G; Men, P; Miller, SC | 2 |
2 other study(ies) available for docosyl-triethylenetetraminepentaacetic acid and Osteoporosis, Postmenopausal
| Article | Year |
|---|---|
Age-associated iron accumulation in bone: implications for postmenopausal osteoporosis and a new target for prevention and treatment by chelation.
Topics: Acetates; Aging; Animals; Bone Density; Chelation Therapy; Female; Humans; Iron; Iron Chelating Agents; Osteoporosis, Postmenopausal; Ovariectomy; Ovary; Rats; Rats, Sprague-Dawley; Trientine | 2006 |
Therapeutic effects of an oral chelator targeting skeletal tissue damage in experimental postmenopausal osteoporosis in rats.
Topics: Acetates; Animals; Electron Spin Resonance Spectroscopy; Female; Free Radicals; Humans; Iron; Iron Chelating Agents; Muscle, Skeletal; Osteoporosis, Postmenopausal; Oxidative Stress; Rats; Rats, Sprague-Dawley; Trientine | 2008 |